These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Chronic lymphocytic leukemia (CLL) treatment: So many choices, such great options. Sharma S; Rai KR Cancer; 2019 May; 125(9):1432-1440. PubMed ID: 30807655 [TBL] [Abstract][Full Text] [Related]
13. Targeted therapies for CLL: Practical issues with the changing treatment paradigm. Jain N; O'Brien S Blood Rev; 2016 May; 30(3):233-44. PubMed ID: 26776345 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms of ibrutinib resistance in chronic lymphocytic leukemia and alternative treatment strategies. Lama TG; Kyung D; O'Brien S Expert Rev Hematol; 2020 Aug; 13(8):871-883. PubMed ID: 32673127 [TBL] [Abstract][Full Text] [Related]
15. The fading star of obinutuzumab-chlorambucil regimen in patients with comorbidities with chronic lymphocytic leukemia - are we ready for chemo-free immunotherapy approach? Milunović V; Mišura Jakobac K; Mandac Rogulj I; Martinović M; Radić-Krišto D; Ostojić Kolonić S Expert Rev Hematol; 2020 Jul; 13(7):771-779. PubMed ID: 32579408 [TBL] [Abstract][Full Text] [Related]
16. Frontline Treatment for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Targeted Therapy vs. Chemoimmunotherapy. Small S; Ma S Curr Hematol Malig Rep; 2021 Aug; 16(4):325-335. PubMed ID: 34021874 [TBL] [Abstract][Full Text] [Related]
17. Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures. Hallek M; Al-Sawaf O Am J Hematol; 2021 Dec; 96(12):1679-1705. PubMed ID: 34625994 [TBL] [Abstract][Full Text] [Related]